TD Cowen had upgraded Merck in early 2024 based on confidence in Keytruda and Gardasil’s performance, a lack of binary risks, and an attractive valuation. However, setbacks in Gardasil’s China ...

Investing.com -- TD Cowen downgraded Merck & Company Inc (NYSE:MRK) to "Hold" on concerns over uncertainty surrounding Gardasil sales, a slowdown in business development, and the looming loss of ...

Investing.com -- TD Cowen downgraded Merck &Company Inc (NYSE:MRK) to "Hold" on concerns over uncertainty surrounding Gardasil sales, a slowdown in business development, and the looming loss of ...

On Tuesday, TD Cowen began coverage of Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy rating, citing the company's strong position in the endocrine market and the high potential of its product ...

In a report released today, Andrew Kligerman from TD Cowen maintained a Buy rating on W. R. Berkley Corporation (WRB – Research Report), with a price target of $73.00. The company’s shares ...

TD Cowen analyst Andrew Kligerman maintained a Buy rating on Arch Capital Group (ACGL – Research Report) today and set a price target of $141.00. The company’s shares closed yesterday at $91.46.

Thomas, PhD, CEO and founder of Metagenomi, will participate in a fireside chat at TD Cowen's 45th Annual Health Care Conference on Wednesday, March 5, 2025, from 1:10-1:40 p.m. ET in Boston.

On Monday, TD Cowen's analysts adjusted their outlook on Neste Oyj (NESTE:FH) (OTC: NTOIY), reducing the price target from €19.00 to €15.00 while maintaining a Hold rating on the stock. The stock, ...

We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other ...

Hannah Jewell writes The 7, The Washington Post’s morning briefing, which is available each weekday from 7 a.m. to 10 a.m. Eastern time on mobile, desktop and inboxes. She is also the host of ...